b-Fast.ai
About
b-Fast.ai has developed a novel and patented method for the rapid identification of bacterial pathogens and their susceptibility to antibiotics. Their technology aims to deliver results within 45 minutes, significantly reducing the time required for clinical decision-making in infectious disease treatment.
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does b-Fast.ai do?
b-Fast.ai has developed a novel and patented method for the rapid identification of bacterial pathogens and their susceptibility to antibiotics. Their technology aims to deliver results within 45 minutes, significantly reducing the time required for clinical decision-making in infectious disease treatment.
Where is b-Fast.ai headquartered?
b-Fast.ai is headquartered in Tel Aviv, Israel.
When was b-Fast.ai founded?
b-Fast.ai was founded in 2022.
What industry does b-Fast.ai operate in?
b-Fast.ai operates in Healthcare, HealthTech, MedTech, Biotech, Drug Discovery, Clinical Trials.
What is b-Fast.ai's current status?
b-Fast.ai's current operating status is: Inactive.